A Group Wide Biology and Banking Study for Phase II Study of R1507

Trial Profile

A Group Wide Biology and Banking Study for Phase II Study of R1507

Completed
Phase of Trial: Phase II

Latest Information Update: 26 May 2017

At a glance

  • Drugs Teprotumumab (Primary)
  • Indications Sarcoma
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 27 Nov 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Sep 2013 New trial record
    • 26 Sep 2013 According to the ClinicalTrials.gov record, the recruitment status of this study is unknown because the information has not been verified recently.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top